© 2021 MJH Life Sciences and Pharmacy Times. All rights reserved.
© 2021 MJH Life Sciences™ and Pharmacy Times. All rights reserved.
April 09, 2021
Recent estimates suggest that 40% of near-poor individuals on Medicare spend at least one-fifth of their income on health care expenses, according to the study.
April 01, 2021
The researchers analyzed millions of pharmacy transactions by more than 600,000 people in the United States from 2017 to 2019 in order to get a better sense of how vouchers and other point-of-sale co-payment offsets are used.
March 15, 2021
The Medicare payment amount for administering the COVID-19 vaccine is increasing, according to a statement from the Centers for Medicare and Medicaid Services.
The increasing prices of the drugs used to treat hookworm, roundworm (ascariasis), and whipworm (trichuriasis) is driving increased costs for patients with Medicaid or private insurance, as well as a potential decrease in the quality of care those patients receive.
March 12, 2021
The pharmaceutical supply chain, while always central to health care, will play an even more crucial role as the pandemic continues to threaten the financial viability of hospitals and health systems, large and small.
March 11, 2021
The receipt of preventive care for youth enrolled in Medicaid managed care fell significantly short of the annual goal set by the Centers for Medicare and Medicaid Services (CMS).
March 03, 2021
Third party payers have concluded that the fee-for-service system is no longer financially viable and that a new approach is necessary.
February 24, 2021
The estimate is based on a new analysis of out-of-pocket costs for influenza-related hospitalizations in 2018 that were paid by people with Medicare Advantage plans, which are Medicare plans run by private insurance companies.
February 18, 2021
Communication plays a critical role in coping strategies around health and financial challenges, according to a recent qualitative study that investigated how people cope with these challenges.
February 09, 2021
Across all of the nations studied, investigators found that the United States accounted for 58% of all prescription drug sales but just 24% of the volume.